Hook & thesis:
Cerebras (CBRS) just altered the narrative. Recent results and commentary push the company from promising hardware story to one that shows a real earnings curve: accelerating revenue, a multi-billion-dollar set of remaining performance obligations, and evidence of margin leverage in the model. That combination - growth plus a visible backlog - is exactly what can convert speculative multiple expansion into sustained upside.
That said, the market is skeptical. Shares trade near $164.40 after a pullback from the 52-week high of $386.34, technical indicators are weak, and the company still carries concentration and competitive risks. The trade proposed below accepts those headwinds while using a tight, defined stop and a realistic target tied to a re-rating that would be consistent with the new revenue profile.
What the business does and why the market should care
Cerebras designs wafer-scale processors and AI systems optimized for large-model training and inference. Customers buy a product that promises material speed and throughput advantages for specialized AI workloads. The reason this matters to investors is simple: large models and hyperscale customers need compute capacity, and Cerebras claims the kind of performance that can reduce total cost of ownership for certain classes of workloads.
Two fundamental drivers underpin the investment case right now:
- Backlog cadence: Management reported $25.4 billion in remaining performance obligations and cited more than 600 MW of data-center capacity under contract. That is not soft demand; it's a pipeline that gives revenue visibility if execution follows.
- Earnings inflection: Recent quarters showed core revenue growth above 100% year-over-year and management is guiding core revenue in the $880-890 million range for 2026. Even if those numbers require careful modeling, they create a much larger revenue base versus the company a year ago and justify higher multiples if margins follow.
Supporting data from the company and market:
- Current price: $164.40.
- Market cap: approximately $38.99 billion.
- 52-week range: $160.81 - $386.34.
- Recent operating backdrop from results and press: core revenue growth of ~103% (Q2 2026), reported revenue figure of ~$510 million in the trailing period cited by coverage, guidance implying $880-890 million in core revenue for 2026, and $25.4 billion remaining performance obligations.
- Profitability is mixed in coverage: some pieces cite a move toward profitability while others note net losses in the past (one reference to ~$450.5 million net losses); margin improvement will be the key watch.
- Technicals: 10-day SMA at $177.11, 20-day SMA $187.93, 50-day SMA $199.31; RSI 37.6 and MACD indicating bearish momentum. The stock is below short- and medium-term moving averages, which increases the chance of a near-term bounce-play being needed to reverse sentiment.
- Short interest: latest settlement shows ~14.12 million shares short, with days-to-cover ~2.1. Short volume as a proportion of trading has been elevated in recent sessions.
Valuation framing
On the surface the stock looks expensive: the market values the company near $39 billion while 2026 core revenue guidance sits roughly in the $880-890 million band. That implies roughly 44x expected revenue, which is a stretch relative to established peers and historical norms for hardware vendors. The market is pricing not only growth but a dominant market position and dramatic margin expansion - outcomes that require execution.
Still, valuation is not a binary argument. If management converts a material portion of the $25.4B backlog over the next 12-24 months and margins expand even modestly, a re-rating toward a materially higher enterprise value could be justified. The trade here is a bet that the earnings curve will be visible and that the market will be willing to pay for a clearer revenue and margin run-rate.
Trade plan - actionable terms
| Action | Entry | Stop loss | Target | Horizon |
|---|---|---|---|---|
| Long | $165.00 | $150.00 | $230.00 | Long term (180 trading days) |
Why these levels?
- Entry at $165 sits near the current price and allows participation if the stock stabilizes after the short-term technical weakness. It also keeps a tight risk budget relative to the volatility implied by the 52-week trading range.
- Stop at $150 limits downside if the backlog converts poorly, large customers pull back, or the competitive environment causes margin erosion. $150 is a technical level below recent intra-day ranges and keeps risk controlled.
- Target of $230 assumes the market begins to price a clearer revenue and margin runway. That would represent a roughly 39% move from the entry and is consistent with a multiple expansion toward a valuation that respects strong revenue growth but still acknowledges competitive pressure.
- Horizon of long term (180 trading days) is chosen because backlog conversion, contract fulfillment, and meaningful margin moves typically take multiple quarters to become visible. Expect newsflow and quarterly reports to be the main catalysts.
Catalysts to watch
- Upcoming quarterly results and guidance updates that confirm or revise the $880-890M core revenue outlook.
- Quarterly or press disclosure showing conversion of the $25.4B remaining performance obligations into booked revenue or signed delivery milestones tied to the 600+ MW data-center capacity figure.
- Large-customer announcements or expansion of existing contracts; any news that reduces customer concentration would be especially positive.
- Clear margin improvement - gross margin expansion or operating leverage in sequential quarters that reduces the net loss trend.
Risks and counterarguments
There are at least four concrete risks that could invalidate the trade:
- Execution risk: A huge RPO is only valuable if the company can convert those obligations to delivered product and recognized revenue. Supply chain, manufacturing, or deployment issues could delay recognition.
- Customer concentration: Several reports note that three customers account for roughly three-quarters of revenue in some periods. Losing or slowing purchases from one of those customers would materially hurt growth and sentiment.
- Competitive pressure: Incumbent GPU vendors and large cloud players continue to invest heavily. NVIDIA and AMD's scale and customer relationships could cap Cerebras' pricing power or deter new customers from adopting wafer-scale hardware.
- Valuation sensitivity: At ~44x expected revenue, the stock needs continued beats and visible margin improvement to justify the current multiple. Any soft print could trigger a swift re-rating downward.
Counterargument to our thesis
One valid counterargument is that the backlog figure overstates near-term revenue visibility. Large RPO numbers can include long-tail services, embedded recurring revenue, and multi-year commitments that do not translate into immediate margin-accretive revenue. In that scenario, the market would maintain a healthy discount until revenue and free cash flow are recurring and less dependent on a handful of hyperscalers. If that proves true, the current valuation remains unjustified and the stock may revisit the low- to mid-$100s quickly.
What would change my mind
I will reassess this trade if any of the following occurs:
- Management guides materially below the $880-890M core revenue range or reduces backlog conversion estimates.
- Reported gross margin or operating margins deteriorate or fail to show sequential improvement while revenue accelerates (suggesting poor mix or high fulfillment costs).
- Public evidence that a major customer reduces orders or the company discloses cancellations or large delays in the delivery schedule.
- Competitive development: a clear announcement from a large incumbent that materially reduces Cerebras' competitive differentiation on cost or performance for the most relevant workloads.
Position sizing & risk management
This is a high-risk trade. Position size should reflect the stop placement and the volatility profile - plan to risk a small percentage of portfolio capital on the initial position and be prepared to re-evaluate after the next earnings release or a material contract update. The $15 stop from entry represents defined risk and avoids open-ended downside exposure.
Conclusion
Cerebras' recent earnings cadence and the sheer scale of its reported backlog change how I view the stock: it moves from speculative hardware promise to a company with an earnings curve that can be modeled and tested. That does not remove sizable execution and competitive risks, but it does provide a pathway for the market to re-rate the name if the company converts backlog into revenue and margin improvement in the coming quarters.
The recommended trade is a long entry at $165 with a $150 stop and a $230 target over a long-term horizon (180 trading days). Keep position sizes conservative, monitor backlog conversion and margin trends closely, and be ready to cut if guidance or execution disappoints.
Trade idea posted 10/11/2026 — maintain discipline: the upside is compelling only if the earnings curve shows up in hard revenue and margin outcomes.